kho rau lub raum cell carcinoma

Kev kho rau lub raum cell carcinoma (RCC) koom nrog ntau txoj hauv kev, suav nrog kev phais, kev kho mob, kev tiv thaiv kab mob, thiab kev kho hluav taws xob. Qhov kev xaiv ntawm kev kho mob nyob ntawm tej yam xws li theem ntawm tus mob qog noj ntshav, tus neeg mob txoj kev noj qab haus huv tag nrho, thiab kev nyiam ntawm tus kheej. Kev tshawb pom ntxov thiab kev cuam tshuam raws sijhawm yog qhov tseem ceeb rau kev txhim kho cov txiaj ntsig.Kev nkag siab rau lub raum Cell CarcinomaLub raum cell carcinoma (RCC) yog hom mob qog noj ntshav ntau tshaj plaws rau cov neeg laus. Nws tshwm sim nyob rau hauv ob sab phlu ntawm lub proximal convoluted tubule, ib feem ntawm lub raum uas lim cov ntshav thiab tshem tawm cov khoom pov tseg. Txawm hais tias qhov laj thawj tiag tiag ntawm RCC tsis yog ib txwm paub meej, qee yam kev pheej hmoo cuam tshuam nrog kev nce ntxiv ntawm tus kab mob. Cov kev pheej hmoo no suav nrog kev haus luam yeeb, rog rog, ntshav siab, thiab caj ces xws li kab mob von Hippel-Lindau (VHL). Ntawm Shandong Baofa Cancer Research Institute, peb tau cog lus los muab cov ntaub ntawv qhia meej thiab qib siab kev kho mob Cov kev xaiv rau cov neeg mob RCC.Types ntawm Renal Cell Carcinoma Muaj ntau ntau hom RCC, txhua tus muaj cov yam ntxwv sib txawv thiab cov lus teb sib txawv rau kev kho mob. Feem ntau cov subtypes muaj xws li: Clear Cell RCC: Qhov no yog hom kev nthuav dav tshaj plaws, suav txog li 70-80% ntawm cov neeg mob. Papillary RCC: Qhov thib ob feem ntau hom, sawv cev kwv yees li 10-15% ntawm cov neeg mob. Chromophobe RCC: Ib hom tsawg dua, ua txog li 5% ntawm cov neeg mob. Cov khoom siv hluav taws xob RCC: Ib daim ntawv uas tsis tshua muaj thiab txhoj puab heev ntawm RCC.Treatment Options for Renal Cell CarcinomaThe kev kho mob txoj hauv kev rau RCC nyob ntawm ntau yam, suav nrog theem ntawm tus mob qog noj ntshav, tus neeg mob txoj kev noj qab haus huv tag nrho, thiab qhov tshwj xeeb ntawm RCC. Feem ntau kev kho mob Cov kev kho mob suav nrog kev phais, kev kho mob, kev tiv thaiv kab mob, thiab kev kho hluav taws xob.Kev kho mob phais feem ntau yog thawj zaug. kho rau lub raum cell carcinoma, tshwj xeeb tshaj yog thaum mob qog noj ntshav nyob rau hauv lub raum. Cov kev xaiv phais muaj xws li: Radical nephrectomy: Qhov no suav nrog kev tshem tawm tag nrho ntawm lub raum cuam tshuam, nrog rau cov ntaub so ntswg ib puag ncig xws li qog adrenal thiab qog ntshav. Ib nrab nephrectomy: Qhov no tsuas yog tshem tawm cov qog thiab cov npoo me me ntawm cov ntaub so ntswg noj qab haus huv, khaws cia kom ntau li ntau tau. Txoj hauv kev no feem ntau nyiam rau cov qog me me los yog thaum tus neeg mob tsuas muaj ib lub raum xwb.Targeted TherapyTargeted therapies yog cov tshuaj uas tshwj xeeb rau cov molecules koom nrog hauv kev loj hlob ntawm cov qog nqaij hlav cancer thiab ciaj sia. Cov kev kho no tuaj yeem ua tau zoo tshwj xeeb hauv RCC qib siab. Cov kev kho mob uas muaj hom phiaj muaj xws li: VEGF inhibitors: Cov tshuaj no thaiv txoj kev vascular endothelial growth factor (VEGF), uas yog qhov tseem ceeb rau kev tsim cov hlab ntsha tshiab uas muab cov qog. Piv txwv xws li sunitinib (Sutent), sorafenib (Nexavar), pazopanib (Votrient), axitinib (Inlyta), thiab cabozantinib (Cabometyx). mTOR inhibitors: Cov tshuaj no thaiv lub hom phiaj mammalian ntawm rapamycin (mTOR) txoj kev, uas tswj cov cell loj hlob thiab metabolism. Piv txwv suav nrog temsirolimus (Torisel) thiab everolimus (Afinitor).ImmunotherapyImmunotherapy siv lub zog ntawm lub cev tiv thaiv kab mob los tiv thaiv kab mob. Immunotherapy tshuaj rau RCC muaj xws li: Immune checkpoint inhibitors: Cov tshuaj no thaiv cov proteins uas tiv thaiv lub cev tiv thaiv kab mob los ntawm kev tawm tsam cov qog nqaij hlav cancer. Piv txwv xws li nivolumab (Opdivo), pembrolizumab (Keytruda), ipilimumab (Yervoy), thiab atezolizumab (Tecentriq). Nivolumab feem ntau ua ke nrog ipilimumab rau cov kab mob siab heev. Cytokines: High-dose interleukin-2 (IL-2) thiab interferon-alpha (IFN-α) yog cytokines uas tuaj yeem txhawb kev tiv thaiv kab mob. Txawm li cas los xij, cov tshuaj no tuaj yeem muaj kev phiv loj heev thiab tsis tshua siv tam sim no vim muaj cov tshuaj tiv thaiv kab mob tshiab.Radiation TherapyRadiation therapy siv cov hluav taws xob hluav taws xob siab los tua cov qog nqaij hlav cancer. Nws tsis yog feem ntau yog thawj kho rau lub raum cell carcinoma, tab sis nws tuaj yeem siv los tswj qhov mob lossis lwm yam tsos mob tshwm sim los ntawm kev mob qog noj ntshav uas tau kis mus rau lwm qhov ntawm lub cev. Nws yog qee zaum siv tom qab phais yog tias muaj kev pheej hmoo mob qog noj ntshav yuav rov qab los yog qee qhov qog tsis tuaj yeem raug tshem tawm. Stereotactic body radiation therapy (SBRT) muab cov koob tshuaj ntau ntawm cov hluav taws xob mus rau thaj chaw uas muaj lub hom phiaj thiab qee zaum siv rau cov qog nqaij hlav hauv lub raum. Cov theem ntawm lub raum Cell Carcinoma thiab Kev Kho Mob Cov theem ntawm RCC yog qhov tseem ceeb hauv kev txiav txim siab qhov tsim nyog. kev kho mob mus kom ze. Cov theem yog nyob ntawm qhov loj thiab qhov chaw ntawm cov qog, seb nws puas tau kis mus rau cov qog nqaij hlav nyob ze, thiab seb nws puas tau metastasized rau cov kab mob nyob deb. Kev kho mob Feem ntau cuam tshuam nrog kev phais tshem tawm ntawm cov qog, los ntawm ib nrab lossis radical nephrectomy.Stage II Renal Cell CarcinomaCov qog loj dua 7 cm tab sis tseem nyob hauv lub raum. Kev kho mob Feem ntau suav nrog radical nephrectomy.Stage III Renal Cell CarcinomaCov qog tau kis mus rau cov qog ntshav nyob ze lossis tau loj hlob mus rau hauv cov hlab ntsha loj lossis cov ntaub so ntswg ib puag ncig. Kev kho mob Tej zaum yuav koom nrog radical nephrectomy, lymph node dissection, thiab tejzaum nws adjuvant therapy (piv txwv li, targeted therapy or immunotherapy).Stage IV Renal Cell CarcinomaThe cancer has metastasized to far organs, such as the ntsws, pob txha, lossis hlwb. Kev kho mob Cov kev xaiv yuav suav nrog kev phais kom tshem tawm cov qog loj (cytoreductive nephrectomy), kev kho mob, kev tiv thaiv kab mob, kev kho hluav taws xob, lossis kev sib xyaw ua ke ntawm cov txheej txheem no. Kev sim tshuaj kho mob kuj yog ib qho kev xaiv.Living with Renal Cell CarcinomaLiving with RCC tuaj yeem nthuav tawm ntau yam teeb meem, ob qho tib si ntawm lub cev thiab lub siab lub ntsws. Nws yog ib qho tseem ceeb kom muaj kev txhawb nqa muaj zog thiab nkag mus rau kev kho mob dav dav. Cov neeg mob yuav muaj kev phiv los ntawm kev kho mob, xws li qaug zog, xeev siab, raws plab, thiab pob khaus ntawm daim tawv nqaij. Tswj cov kev mob tshwm sim no yog ib feem tseem ceeb ntawm kev kho mob qog noj ntshav. Tsis tas li ntawd, kev tswj hwm txoj kev noj qab haus huv, suav nrog kev noj zaub mov kom zoo thiab kev tawm dag zog tsis tu ncua, tuaj yeem pab txhim kho kev noj qab haus huv tag nrho. Ntawm Shandong Baofa Cancer Research Institute, peb pab neeg mob siab rau muab kev saib xyuas zoo thiab tus kheej kev kho mob npaj pab cov neeg mob tswj lawv RCC thiab txhim kho lawv lub neej zoo. Peb nyob hauv Jinan Innovation Zone, thiab peb lub hom phiaj ua raws li 'Ua hauv Tuam Tshoj 2025' lub tswv yim. Tsis ntev los no Cov Kev Txhim Kho Hauv Lub Raum Cell Carcinoma Kev Kho Mob ntawm RCC kev kho mob yog hloov zuj zus mus tas li, nrog rau cov kev kho tshiab thiab kev txhim kho. Cov kev nce qib tsis ntev los no suav nrog: Combination Immunotherapy: Kev sib xyaw cov tshuaj tiv thaiv kab mob sib txawv, xws li nivolumab thiab ipilimumab, tau pom cov txiaj ntsig tau zoo hauv qee cov neeg mob uas muaj RCC siab heev. Txhim kho Lub Hom Phiaj Therapies: Cov tiam tshiab ntawm cov hom phiaj kho tau raug tsim los nrog kev ua tau zoo dua qub thiab muaj kev phiv tsawg dua. Tshuaj kho tus kheej: Cov kws tshawb fawb tau ua haujlwm txhawm rau txheeb xyuas biomarkers uas tuaj yeem pab kwv yees seb cov neeg mob twg feem ntau yuav teb rau qhov tshwj xeeb kev kho mobs.Prognosis rau Renal Cell CarcinomaCov kev mob tshwm sim rau RCC txawv nyob ntawm theem ntawm tus mob qog noj ntshav, tus neeg mob qhov kev noj qab haus huv tag nrho, thiab cov lus teb rau kev kho mob. Kev tshawb pom ntxov thiab kev cuam tshuam raws sijhawm yog qhov tseem ceeb rau kev txhim kho cov txiaj ntsig. Cov neeg mob nrog RCC hauv zos uas tau txais kev phais mob muaj feem yuav kho tau zoo. Txawm li cas los xij, qhov kev kwv yees tsis zoo rau cov neeg mob uas muaj RCC siab heev. Kev tshawb fawb tsis tu ncua yog tsom rau kev tsim kho tshiab thiab ua tau zoo dua kev kho mobs los txhim kho qhov kev cia siab rau txhua tus neeg mob nrog RCC.Clinical TrialsClinical trials yog cov kev tshawb fawb tshawb fawb uas ntsuas qhov tshiab kev kho mobs los yog txoj hauv kev rau RCC. Kev koom nrog hauv kev sim tshuaj tuaj yeem muab kev nkag mus rau cov kev kho mob uas tseem tsis tau muaj dav. Cov neeg mob xav paub ntau ntxiv txog kev sim tshuaj yuav tsum tham nrog lawv tus kws kho mob.Cov ntaub ntawv piv txwv: Cov Nqis ciaj sia los ntawm theem 5-Year Survival Rate Theem I 81-93% Qib II 74-91% Qib III 53-83% Qib IV 8-20% Tau qhov twg los: American Cancer Society (www.cancer.org)